NASHVILLE, Tenn.--(BUSINESS WIRE)--Premerus, the nation’s only company dedicated to advancing clinical accuracy through diagnostic excellence, summons healthcare consumers and industry stakeholders to raise their levels of concern about the high rate of breast cancer misdiagnoses. Medical misdiagnosis not only impacts outcomes and generates patient anxiety, but it also significantly raises costs for the entire American healthcare system.
“Diagnostic errors of breast cancer merit a state of heightened alert,” says Gregg Allen, M.D., chief medical officer of Premerus. “We know that error rates vary dramatically depending upon which radiologist is reading the mammogram. It’s time for our healthcare system to respond, and it begins with improved accuracy in the reading of every mammogram. As a result, we should expect to generate better survival rates while decreasing the overall costs associated with breast cancer treatment. “
source: Business Wire
No comments:
Post a Comment